The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children.
Observational evidence suggests that pneumococcal conjugate vaccines (PCVs) are more effective at reducing the incidence of hypoxaemic pneumonia compared to non-hypoxaemic pneumonia. We examined the impact of 10-valent PCV (PCV10, Synflorix) on hypoxaemic pneumonia hospital admissions using data fro...
Saved in:
| Main Authors: | Ilsa L Haeusler, E Wangeci Kagucia, Christian Bottomley, Mark Otiende, Joyce Nyiro, J Anthony G Scott |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://doi.org/10.1371/journal.pgph.0004888 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.
by: Philip Ayieko, et al.
Published: (2013-01-01) -
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT
by: James J McNamee, et al.
Published: (2025-07-01) -
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction
by: Sanne G.J. Mourmans, et al.
Published: (2025-02-01) -
Home-based management of hypoxaemic COVID-19 patients: design of the Therapy@Home pilot study
by: Frans H Rutten, et al.
Published: (2024-01-01) -
13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)